Medical Director of The Royal Marsden and Consultant Clinical Oncologist in Urology
Dr Nicholas van As was appointed Medical Director of The Royal Marsden in January 2016. He has been a Consultant Clinical Oncologist in the Urology Unit in the hospital for eight years and is Clinical Lead for stereotactic body radiotherapy (SBRT) and CyberKnife. Dr van As is also Co-Chair of the UK SBRT Consortium and the national clinical lead for NHS England’s Commissioning through Evaluation Programme for SBRT. His main research interests are in stereotactic and image-guided radiotherapy, risk prediction in early prostate cancer, and functional MRI and he has published numerous papers on these subjects and delivered presentations at international meetings. He is the Chief Investigator for the PACE trial – an international, randomised controlled trial comparing SBRT to image-guided Radiotherapy (IGRT) and surgery for treating prostate cancer.